20VC: Lessons from Jensen Huang on "Founder Mode" | How to Know if OpenAI or Anthropic Will Kill your Company | How USV Liking Music Made Them $1BN on an Investment | The Five Year Desert to Product Market Fit & a $5.3BN Valuation with Shiv Rao @ Abridge

Vertical AI demands a "true north" thesis and the resilience to survive long market-timing gaps, as demonstrated by Abridge’s journey from a 2018 founding to becoming a $5.3 billion healthcare AI leader. Success in this sector requires embedding technology directly into clinical workflows to capture spoken signals, effectively automating burdensome tasks like documentation and billing. Rather than competing with foundation models, vertical AI companies must leverage them while building in-house models to achieve the low latency and high performance required for high-stakes medical environments. Building trust in a $5.3 trillion industry necessitates a deliberate approach to data, prioritizing clinical utility and compliance over quick monetization. Ultimately, the ability to "earn the right" to access proprietary data and maintain a relentless focus on the end-user experience defines the difference between transient features and enduring, category-defining companies.